Chemical inhibitors of TTLL1 target the protein's reliance on microtubule dynamics to exert its tubulin-modifying function. Colchicine, a compound known for its ability to inhibit microtubule polymerization, can hamper the function of TTLL1 by disrupting the formation of the microtubule structures that TTLL1 modifies. Similarly, Nocodazole's action as a microtubule-depolymerizing agent directly impacts TTLL1 by altering the normal polymerization and depolymerization cycle of tubulin, the substrate of TTLL1. Vinblastine and Vincristine, both microtubule-targeting agents, bind to tubulin and prevent its polymerization, which in turn can inhibit TTLL1 as it cannot modify what is not properly assembled. Paclitaxel takes an opposite approach by stabilizing microtubules and preventing their disassembly, thereby indirectly inhibiting TTLL1 by locking its substrate into an inaccessible form, precluding modification.
In the same vein, Podophyllotoxin can inhibit TTLL1 by stabilizing tubulin in a non-polymerized state, preventing the formation of microtubule structures essential for TTLL1's activity. Eribulin exerts its inhibitory effect on TTLL1 by selectively inhibiting the growth phase of microtubules without affecting the shortening phase, leading to improperly formed microtubules and, consequently, inhibition of TTLL1 activity. Peloruside A shares a similar mechanism by stabilizing microtubules, which can inhibit TTLL1 by disallowing the dynamic changes required for its activity. Griseofulvin interferes with microtubule assembly, thus can inhibit the function of TTLL1, which depends on the proper assembly of microtubules to carry out its enzymatic duties. Combretastatin A4 binds to the colchicine site on tubulin, inhibiting its polymerization and potentially preventing TTLL1 from modifying the microtubule network. Finally, Mebendazole and Albendazole both disrupt microtubule formation by targeting tubulin polymerization, which can inhibit TTLL1 since it needs polymerized tubulin to functionally modify the microtubule network.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine can inhibit microtubule polymerization, which is essential for the function of TTLL1 as it is involved in tubulin modification. Inhibiting microtubule dynamics can, therefore, inhibit TTLL1 activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole disrupts microtubule networks by inhibiting their polymerization. Since TTLL1 functions in relation to microtubules, nocodazole's action would inhibit TTLL1's ability to modify tubulin. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Vinblastine can bind to tubulin, inhibiting tubulin polymerization into microtubules, which subsequently inhibits TTLL1 since its activity is associated with microtubule function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly, which can inhibit TTLL1 by locking its substrate in an inaccessible form, thus preventing TTLL1 from performing its function on microtubules. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $82.00 | 1 | |
Podophyllotoxin inhibits microtubule assembly. By stabilizing tubulin in a non-polymerized form, it can inhibit TTLL1 activity, which relies on the dynamic state of microtubules. | ||||||
Eribulin | 253128-41-5 | sc-507547 | 5 mg | $865.00 | ||
Eribulin inhibits the growth phase of microtubules without affecting the shortening phase, leading to an inhibition of the proper formation of microtubules, which is necessary for TTLL1 function. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $83.00 $216.00 $586.00 | 4 | |
Griseofulvin disrupts microtubule function by interfering with microtubule assembly, which in turn would inhibit TTLL1 since it is dependent on properly assembled microtubules for its activity. | ||||||
Combrestatin A4 | 117048-59-6 | sc-204697 sc-204697A | 1 mg 5 mg | $45.00 $79.00 | ||
Combretastatin A4 binds to tubulin at the colchicine site and inhibits its polymerization, thus potentially inhibiting TTLL1 activity by preventing the formation of its microtubule substrate. | ||||||
Mebendazole | 31431-39-7 | sc-204798 sc-204798A | 5 g 25 g | $45.00 $87.00 | 2 | |
Mebendazole disrupts microtubule formation by binding to beta-tubulin, inhibiting its polymerization, and thus could inhibit TTLL1, which requires microtubule structures to function. | ||||||
Albendazole | 54965-21-8 | sc-210771 | 100 mg | $209.00 | 1 | |
Albendazole targets tubulin and inhibits its polymerization, which could inhibit TTLL1 activity as it needs polymerized tubulin to carry out its modifying functions. | ||||||